.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

PD Dr. Martin Empting

Saarbrücken/ DE

Helmholtz-Institut für Pharmazeutische Forschung Saarland

Vortrag

26.09.2023
11:35 – 11:50 10 Min. 5 Min.
Highlight-Vortrag
S-5-2
Learning to block bacterial pathogenicity – how to exploit this new anti-infective modality on the example of quorum sensing inhibitors
Antimicrobial Resistance

Weitere Beteiligungen

25.09.2023
Poster
P-1-87
Disrupting Kaposi's sarcoma-associated herpesvirus (KSHV) latent replication with a small molecule inhibitor and PROTACs
Chronic Infections
25.09.2023
Poster
P-1-93
Thioxothiazolo[3,4-a]quinazoline derivatives inhibit the human cytomegalovirus alkaline nuclease
Chronic Infections
25.09.2023
Poster
P-1-108
First-in-class LMP1-TRAF2 interaction inhibitors block Epstein-Barr virus oncoprotein LMP1-induced signaling and interfere with LCL and PTLD survival
Chronic Infections
25.09.2023
Poster
P-1-119
Novel Small Chemical Compounds Blocking Herpes Simplex Virus Assembly
Chronic Infections
26.09.2023
11:35 – 11:50 10 Min. 5 Min.
Highlight-Vortrag
S-5-2
Learning to block bacterial pathogenicity – how to exploit this new anti-infective modality on the example of quorum sensing inhibitors
Antimicrobial Resistance